Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool

Clinical Transplantation

Volumn 17, Issue 4, 2003, Pages 308-324

  López Navidad, Antonio ^a   Caballero, Francisco ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Aging donor; Bacterial infection; Domino transplant; Extended donor; Hepatitis B virus; Hepatitis C virus

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CADAVER DONOR; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION PREVENTION; INTOXICATION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; LIVER TRANSPLANTATION; MYCOSIS; ORGAN DONOR; ORGAN INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT; REVIEW; SURVIVAL; TIME;

ADULT; AGE FACTORS; AGED; BACTERIAL INFECTIONS; CADAVER; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONORS; MYCOSES; POISONING; SAFETY; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0041620511     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00119.x     Document Type: Review

References (223)

1. Rosengard BR, Feng S, Alfrey EJ et al. Report of the crystal city meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002: 2: 701.
2. Zaro JC, Rosengard BR, Armstrong WF et al. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation 2002: 106: 836.
3. The critical organ shortage. United Network for Organ Sharing, 2001. http://www.unos.org.
4. Cecka JM, Terasaki PI, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue 1Typing Laboratory, 1997: 25.
5. Freeman RB, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transplant 2000: 6: 543.
6. Brandsater B, Höckerstedt K, Friman S et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation - 12 years experience in the nordic countries. Liver Transplant 2002: 8: 1055.
7. Laks H, Marelli D. The alternate recipient list for heart transplantation: a model for expansion of the donor pool. Adv Card Surg 1999: 11: 235.
8. Marelli D, Laks H, Bresson J et al. Sixteen-year experience with 1,000 heart transplants at UCLA. In Cecka, Terasaki eds. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center, 2000: 297.
9. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes. Paired donor kidney analysis. Transplantation 2002: 74: 1377.
10. Ojo AO, Hanson JA, Meier-Kriessche HU et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001: 12: 589.
11. López-Navidad A, Caballero F. For a rational approach to the critical points of the cadaveric donation process. Transplant Proc 2001: 33: 795.
12. López-Navidad A, Caballero F, Guirado L, Solá R. The medical-nursing team specialized in the maintenance of the brain-dead heart-beating organ donor exclusively dedicated to caring for the donor reduces donor loss from asystolia to zero. Transplant Proc 2002: 34: 20.
13. Lloyd-Jones H, Wheeldon DR, Smith JA, Potter CDO, Wallvork J, Large SR. An approach to the retrieval of thoracic organs for transplantation. AORN J 1996: 63: 416.
14. Rosendale JD, Kauffman HM, McBride MA et al. Aggressive pharmacologic management results in more transplanted organs. Transplantation 2003: 75: 482.
15. Schnuelle P, Berger S, De Boer J, Persijn G, Van Der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001: 72: 455.
16. Filipponi F, Catalano G, Oliveri F, Biancofiori G, Urbani L, Mosca F. Changing typology of brain death liver donors: characteristics and impact of risk factors on short-term outcome. Gastroenterology 2002: 49: 1395.
17. Kapur S, Bonham CA, Dodson SF, Dvorchik I, Corry RJ. Strategies to expand the donor pool for pancreas transplantation. Transplantation 1999: 67: 284.
18. Guesde R, Barrou B, Leblanc I et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998: 352: 1178.
19. Kinoshita Y, Yahata K, Yoshioka T, Onishi S, Sugimoto T. Long-term renal preservation after brain death maintained with vasopressin and epinephrine. Transplant Int 1990: 3: 15.
20. Kunzerdorf U, Hohenstein B, Oberbarnscheid M et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2002: 2: 292.
21. Penn I. The problem of cancer in organ transplant recipients: an overview. Transpl Sci 1994: 4: 23.
22. Buell JF, Trofe J, Hanaway MJ et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001: 130: 660.
23. Brown P, Gajdusek C, Gibbs CJ, Asher DM. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985: 313: 728.
24. Rutala W, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001: 32: 1348.
25. Kumar P, Pearson JE, Martin DH et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Int Med 1987: 106: 244.
26. MMWR. HIV human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody-North Carolina. JAMA 1987: 258: 308.
27. Samuel D, Castaing D, Adam R et al. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988: i: 1221.
28. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992: 326: 726.
29. Coll P, Montserrat I, Ballester M et al. Epidemiologic evidence of transmission of donor-related bacterial infection through a transplanted heart. J Heart Lung Transplant 1997: 16: 464.
30. Kauffman HM, Bennett LE, McBride MA, Ellison MD. The expanded donor. Transplant Rev 1997: 11: 165.
31. Detry O, Honoré P, Hans MF, Delbouille MH, Jacquet N, Meurisse M. Organ donors with primary central nervous system tumors. Transplantation 2000: 70: 244.
32. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing transplant tumor registry: donors with a history of cancer. Transplantation 2000: 70: 1747.
33. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors. Transplantation 2002: 73: 579.
34. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: donor related malignancies. Transplantation 2002: 74: 358.
35. Feng S, Buell JF, Cherikh WS et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002: 74: 1657.
36. DeMeo DL, Ginns LC. Clinical status of lung transplantation. Transplantation 2001: 72: 1713.
37. Caballero F, López-Navidad A, Leal J, García-Sousa S, Domingo P. Donor age and cause of brain death influence the number of organs retrieved and grafted. Transplant Proc 1999: 31: 2589.
38. Ojo AO, Leichtman AB, Punch JD et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000: 36: 153.
39. Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002: 74: 1281.
40. Miranda B, Fernández Zincke E, Cañón J, Cuende N, Naya MT, Garrido G. Característices, de los donantes renales en España: factores de riesgo y órganos desechados para trasplante. Nefrologia 2001: 21 (Suppl. 4): S111.
41. Di Paolo S, Stallone G, Schena A, Infante B, Gesualdo L, Shena FP. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 2002: 72: 623.
42. Becker YT, Leverson GE, D'Alessandro AM, Sollinger HW, Becker BN. Diabetic kidneys can safely expand the donor pool. Transplantation 2002: 74: 141.
43. Solá R, Guirado L, López Navidad A et al. Renal transplantation with limit donors. To what should the good results obtained be attributed? Transplantation 1998: 66: 1159.
44. Solá R, Guirado L, Díaz JM, López-Navidad A, Caballero F, Gich I. Elderly donor kidney grafts into young recipients: results at 5 years. Transplantation 2002: 73: 1673.
45. Pokorná E, Vítko S, Chadimová M, Schück O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000: 69: 36.
46. Lu AD, Desai D, Myers BD, Dafoe DC, Alfrey EJ. Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. Am J Surg 2000: 180: 470.
47. Andrés A, Morales JM, Herrero J et al. Double versus single renal allografts from aged donors. Transplantation 2000: 69: 2060.
48. Emre S, Schwartz ME, Altaca G et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996: 62: 62.
49. Jiménez Romero C, Moreno González E, Colina Ruíz F et al. Use of octogenarian livers safely expands the donor pool. Transplantation 1999: 68: 572.
50. Grazi GL, Cescon M, Ravaioli M et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001: 1: 61.
51. Cuende N, Grande L, Sanjuan F, Cuervas-Mons V. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation 2002: 73: 1360.
52. Nardo B, Montalti R, Vistoli F et al. Liver transplantation from donor age over 80 years: Italian multicenter experience. Transplantation 2002: 74 (Suppl.): S139.
53. Tenderich G, Koerner MM, Stuettgen B et al. Extended donor criteria. Hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors >60 years of age. Transplantation 1998: 66: 1109.
54. Potapov EV, Loebe M, Hübler M et al. Medium-term results of heart transplantation using donors over 63 years of age. Transplantation 1999: 68: 1834.
55. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000: 118: 1255.
56. Shumway SJ, Hertz MI, Petty MG, Bolman RM, III. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 1994: 57: 92.
57. López-Navidad A, Caballero F, Cabrer C, González-Segura C, Frutos MA. Short- and long-term success of organs transplanted from acute methanol poisoned donors. Clin Transplant 2002: 16: 151.
58. Houyel L, Petit J, Nottin R, Duffet JP, Macé L, Neveux JY. Adult heart transplantation: adverse role of chronic alcoholism in donors on early graft function. J Heart Lung Transplant 1992: 11: 1184.
59. Herrera LA, Castillo J, Martino E, Rabanal JM, Fleitas MG. Orthotopic liver transplantation from a donor with abdominal situs inversus. Transplantation 1996: 62: 133.
60. Mandal AK, Kalligonis AN, Ratner LE. Expanded criteria donors: attempts to increase the renal transplant donor pool. Adv Ren Replace Ther 2000: 7: 117.
61. Rosenthal JT, Khetan U. Transplantation of cadaver kidneys from a donor with crossed nonfused renal ectopia. J Urol 1989: 141: 1184.
62. Stroosma OB, Scheltinga RM, Stubenitsky M, Kootstra G. Horseshoe kidney transplantation: an overview. Clin Transplant 2000: 14: 515.
63. Wigmore SJ, Seeney FM, Pleass HCC, Praseedom RK, Forsythe JLR. Kidney damage during organ retrieval: data from UK national transplant database. Lancet 1999: 354: 1143.
64. Laks H, Gates RN, Ardehali A et al. Orthotopic heart transplantation and concurrent coronary bypass. J Heart Lung Transplant 1993: 12: 810.
65. Jiménez Romero C, Moreno González E, García García I et al. Successful transplantation of a liver graft with a calcified hydatid cyst after back-table resection. Transplantation 1995: 60: 883.
66. Schulak JA, Matthews LA, Hricik DE. Renal transplantation using a kidney with a large benign cyst. Transplantation 1997: 63: 783.
67. Prabhakaran K, Wise B, Colombani PM, Yang SC, Mogayzel PJ. Bilateral cadaveric lobar transplantation from a marginal adult donor to a pediatric recipient. Transplantation 2002: 74: 286.
68. Torrecilla Ortiz C, González-Satué C, Riera Canals L et al. Incidencia y tratamiento de la litiasis urinaria en el injerto renal. Actas Urol Esp 2001: 25: 357.
69. Lu HF, Shekarriz B, Stoller ML. Donor-gifted allograft urolithiasis: early percutaneous management. Urology 2002: 59: 25.
70. Avolio AW, Agnes S, Chirico ASA, Cillo U, Frongillo F, Castagneto M. Successful transplantation of an injured liver. Transplant Proc 2000: 32: 131.
71. Abouna GM, Al-Adnani MSA, Kremer GD, Kumar SA, Daddah SK, Kusma G. Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients. Lancet 1983: 2: 1274.
72. Orlowski JP, Spees EK, Aberle CL, Fitting KM. Successful use of kidneys from diabetic cadaver kidney donors: 67- and 44-month graft survival. Transplantation 1994: 57: 1133.
73. Gómez E, Aguado S, Tejada F, Díaz-Corte C, Seco M, Alvarez-Grande J. Successful transplant of kidneys with diffuse diabetic glomerulosclerosis. Transplantation 1995: 59: 156.
74. Rea R, Smith C, Sandhu K, Kwan J, Tomson C. Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001: 16: 416.
75. Lipkowitz GS, Madden RL, Kurbanov et al. Transplantation and 2-year follow-up of kidneys procured from a cadaver donor with a history of lupus nephritis. Transplantation 2000: 69: 1221.
76. Sakopoulos A, Yum M, Filo RS, Jindal RM. Successful transplantation of kidneys with hemosiderosis. Transplantation 1995: 60: 1180.
77. Flynn MF, Power RE, Murphy DM et al. Successful transplantation of kidneys from a donor with HELLP syndrome-related death. Transpl Int 2001: 14: 108.
78. Woodside KJ, Knisely AS, Strauss AW, Gugliuzza KK, Daller JA. Progression of hepatic damage during cold storage after procurement in a liver and kidney donor with HELLP syndrome. Transplantation 2001: 72: 1990.
79. Firlit CF, Jonasson O, Kahan BD, Bergan JJ. Reye syndrome cadaveric kidneys. Their use in human transplantation. Arch Surg 1974: 109: 797.
80. Richardson CC, Warner OG, Callender CO. Renal transplantation in Reye's syndrome: fate of the recipient - a case report. J Urol 1979: 121: 497.
81. Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. Transplantation 1993: 55: 442.
82. Pastural M, Barrou B, Delcourt A, Bitker MO, Ourahma S, Richard F. Successful kidney transplantation using organs from a donor with disseminated intravascular coagulation and impaired renal function: case report and review of the literature. Nephrol Dial Transplant 2001: 16: 412.
83. Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 1982: 33: 370.
84. Koselj M, Rott T, Vizjak A, Kveder R. IgA nephropathy as a donor-transmitted disease in renal transplant recipients. Transplant Proc 1991: 23: 2643.
85. Curschellas E, Landmann J, Dürig M et al. Morhpologic findings in "zero-hour" biopsies of renal transplants. Clin Nephrol 1991: 36: 215.
86. Urena MAG, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno Sanz C. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology 1999: 46: 1164.
87. Fishbein TM, Fiel MI, Emre S et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997: 64: 248.
88. Markin RS, Wisecarver JL, Radio SJ et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993: 56: 1403.
89. Caballero F, Domingo P, López-Navidad A. Successful liver transplantation using a polycystic donor liver. J Hepatol 1997: 26: 1428.
90. Glanemann M, Langrehr JM, Stange B, Settmacher U, Neuhaus P, Bechstein WO. Polycystic liver grafts for orthotopic liver transplantation. Transplant Proc 2000: 32: 134.
91. Spees EK, Orlowski JP, Schorr WJ, Temple DM, Fink DW, Bruno AJ. Successful use of polycystic cadaver donor kidneys. Transplant Proc 1990: 22: 374.
92. Howard RJ, Reed AI, Van Der Werf WJ, Silkensen JA, Patton PR, Scornik JC. Development of polycystic disease in a kidney 10 years after transplantation. Transplantation 1999: 68: 1620.
93. Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant 2000: 19: 496.
94. Alexandre L, Eschwege P, Blanchet P et al. Effect on kidney graft function of donor creatininemia over 200 μmol/L. Transplant Proc 1996: 28: 2815.
95. Pokorná E, Schück O, Vítko S, Ekberg H. Estimated and measured creatinine clearance are poor predictors of long-term renal graft function and survival. Am J Transplant 2002: 2: 373.
96. Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med 1969: 280: 1367.
97. Dujardin KS, McCully RB, Wijdicks EFM et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 2001: 20: 350.
98. Seiler C, Laske A, Gallino A, Turina M, Jenni R. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant 1992: 11: 867.
99. Boucek MM, Mathis CM, Kanakriyeh MS et al. Donor shortage: use of the dysfunctional donor heart. J Heart Lung Transplant 1993: 12: S186.
100. Kron IL, Tribble CG, Kern JA et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993: 217: 518.
101. Wheeldon DR, Potter CDO, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995: 14: 734.
102. Jeevanandam V, Furukawa S, Prendergast TW, Todd BA, Eisen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996: 62: 1268.
103. Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999: 84: 578.
104. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002: 124: 250.
105. Puskas JD, Winton TL, Miller JD, Scavuzzo M, Patterson GA. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg 1992: 103: 1015.
106. Jorgensen PB, Jorgensen EO, Rosenklint A. Brain death pathogenesis and diagnosis. Acta Neurol Scand 1973: 49: 355.
107. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Int Med 1989: 110: 1001.
108. Weber TR, Freier DT, Turcotte JG. Transplantation of infected kidneys. Clinical and experimental results. Transplantation 1979: 27: 63.
109. Lammermeier DE, Sweeney MS, Haupt HE, Radovancevic B, Duncan M, Frazier OH. Use of potentially infected donor hearts for cardiac transplantation. Ann Thorac Surg 1990: 50: 222.
110. Voltz C, Jacob F, Perrier JF, Strub P, Mariot J. Relation bactériologique entre donneur et receveur d'organes. Enquête à propos de 100 patients en état de mort cérébrale. Agressologie 1992: 33: 154.
111. López-Navidad A, Domingo P, Caballero F, González C, Santiago C. Successful transplantation of organs retrieved from donors with bacterial meningitis. Transplantation 1997: 64: 365.
112. Little DM, Farrell JG, Cunningham PM, Hickey DP. Donor sepsis is not a contraindication to cadaveric organ donation. QJM 1997: 90: 641.
113. Caballero F, López-Navidad A, Domingo P, Solá R, Guirado L, Figueras J. Successful transplantation of organs retrieved from a donor with enterococcal endocarditis. Transpl Int 1998: 11: 387.
114. Calvo V, Borro JM, Morales P et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Chest 1999: 115: 1301.
115. Freeman RB, Giatras I, Falagas ME et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999: 68: 1107.
116. Satoi S, Bramhall SR, Solomon M et al. The use of liver grafts from donors with bacterial meningitis. Transplantation 2001: 72: 1108.
117. Lumbreras C, Sanz F, González A et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001: 33: 722.
118. Gibel LJ, Sterling W, Hoy W, Harford A. Is serological evidence of infection with syphilis a contraindication to kidney donation? Case report and review of the literature. J Urol 1987: 138: 1226.
119. Caballero F, Domingo P, Rabella N, López-Navidad A. Successful transplantation of organs retrieved from a donor with syphilis. Transplantation 1998: 65: 598.
120. Ko WJ, Chu SH, Lee YH et al. Successful prevention of syphilis transmission from a multiple organ donor with serological evidence of syphilis. Transplant Proc 1998: 30: 3667.
121. Zamboni F, Livigni S, Ricci P, Salizzoni M. A single case of orthotopic liver transplantation with a graft from a donor with tetanus. Transpl Int 2000: 13: 234.
122. López-Navidad A, Caballero F. Criterios de selección del donante de órganos respecto a la transmisión de infecciones. Med Clin [Barc] 1999: 113: 637.
123. Prieto M, Gómez MD, Berenguer M et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transplant 2001: 7: 51.
124. Ko WJ, Chou NK, Hsu RB et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic areas. J Heart Lung Transplant 2001: 10: 865.
125. Dodson SF, Bonham A, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of the novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999: 68: 1058.
126. Fong TL, Bunnapradist S, Jordan SC, Cho YW. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United Network of Organ Sharing database between 1994 and 1999. Transplantation 2002: 73: 85.
127. Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transplant 2002: 8: 556.
128. Chan PCK, Lok ASF, Cheng IKP, Chan MK. The impact of donor and recipient hepatitis B surface antigen status on liver disease and survival in renal transplant recipients. Transplantation 1992: 53: 128.
129. González-Peralta RP, Andres JM, Tung FY et al. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. Transplantation 1994: 58: 114.
130. Bedrossian J, Akposso K, Metivier F, Moal MC, Pruna A, Idatte JM. Kidney transplantation with HBsAg+ donors. Transplant Proc 1993: 25: 1481.
131. Dodson SF, Issa S, Araya V et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997: 64: 1582.
132. Delmonico FL, Snydman DR. Organ donor screening for infectious diseases. Review of practice and implications for transplantation. Transplantation 1998: 65: 603.
133. Andrés A, Praga M, Ortuño T, Hernández E, Morales J. El donante marginal en el trasplante renal. Nefrología 2001: 21: 104.
134. Delmonico FL. Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis 2000: 31: 781.
135. Dickson RC, Everhart JE, Lake JR et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997: 113: 668.
136. Barcena Marugán R, García Garzón S, López San Román A et al. Riesgo de transmisión del virus de la hepatitis B de donantes de hígado anti-HBc positivos. Med Clin [Barc] 2001: 116: 125.
137. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001: 1: 185.
138. Roque-Afonso AM, Feray C, Samuel D et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002: 50: 95.
139. Muñoz SJ. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transplant 2002: 8(Suppl. 1): S82.
140. Nery JR, Gedaly R, Vianna R et al. Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transplant Proc 2001: 33: 1521.
141. Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002: 137: 572.
142. Joya-Vázquez PP, Dodson FS, Dvorchik I et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002: 73: 1598.
143. Wachs ME, Amend WJ, Ascher NL et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995: 59: 230.
144. Cirocco R, Zucker K, Contreras N et al. The presence of hepatitis B core antibody does not preclude kidney donation. Lack of viral DNA in the serum and biopsies of core-antibody-positive donors and clinical follow-up. Transplantation 1997: 63: 1702.
145. Satterthwaite R, Ozgu I, Shidban H et al. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation 1997: 64: 432.
146. Blanes M, Gomez D, Cordoba J, Almenar L, Gobernado M, Lopez-Aldeguer J, Dicenta F. Is there any risk of transmission of hepatitis B from heart donors hepatitis B core antibody positive? Transplant Proc 2002: 34: 61.
147. Madayag RM, Johnson LB, Bartlett ST et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997: 64: 1781.
148. Caldwell SH. Hard times and imperfect organs. Liver Transplant Surg 1997: 3: 181.
149. Turner DPJ, Zucherman M, Alexander GJM, Waite J, Wreghitt T. Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation 1997: 63: 775.
150. Chen YS, Wang CC, De Villa VH et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002: 16: 05.
151. De Villa VH, Chen YS, Chen CL. Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003: 75 (Suppl.): S49.
152. Yu AS, Vierling JM, Colquhoun SD et al. Transmission of hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy. Liver Transplant 2001: 7: 513.
153. Loss GE, Mason AL, Blazek J et al. Transplantation of livers from HbcAb positive donors into HbcAb negative recipients: a strategy and preliminary results. Clin Transplant 2001: 15 (Suppl. 6): 55.
154. Candinas D, Joller-Jemelka HI, Schlumpf R et al. Hepatitis C RNA prevalence in a western european organ donor pool and virus transmission by organ transplantation. J Med Microbiol 1994: 41: 220.
155. Pereira BJC, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997: 51: 981.
156. Natov SN, Pereira BJG. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (part 2: hepatitis C virus). Transpl Infect Dis 2002: 4: 124.
157. Ong JP, Barnes DS, Younossi ZM et al. Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology 1999: 30: 1293.
158. Marelli D, Bresson J, Laks H et al. Hepatitis C-positive donors in heart transplantation. Am J Transplant 2002: 2: 443.
159. Bouthot BA, Murthy BVR, Schmid CH, Levey AS, Pereira BJC. Long-term follow-up of hepatitis C virus infection among organ transplant recipients. Transplantation 1997: 63: 849.
160. Testa G, Goldstein RM, Netto G et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998: 65: 925.
161. Vargas HE, Laskus T, Wang LF et al. Outcome of liver transplanation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999: 117: 149.
162. Ghobrial RM, Steadman R, Gornbein J et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001: 234: 384.
163. Velidedeoglu E, Desai NM, Campos L et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002: 73: 582.
164. Morales JM, Campistol JM, Castellano et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995: 47: 236.
165. Ali MK, Light JA, Barhyte DY et al. D. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV + recipients in renal transplantation. Transplantation 1998: 66: 1694.
166. Mandal AK, Kraus ES, Samaniego M et al. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus sero-positive donors. Clin Transplant 2000: 14: 391.
167. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000: 11: 1343.
168. Klimek D, Wiecek A, Kokot F. Czymozna przeszczepic nerki pobrane od osób zmarlych po zatruciu glikolem etylenowym? Pol Arch Med Wewn 1993: 89: 178.
169. Leikin JB, Heyn-Lamb R, Aks S, Erickson T, Snyder J. The toxic patient as a potential organ donor. Am J Emerg Med 1994: 12: 151.
170. Hantson P, Vekemans MC, Vanormelingen P, De Meester J, Persijn G, Mahieu P. Organ procurement after evidence of brain death in victims of acute poisoning. Transplant Proc 1997: 29: 3341.
171. Langer M, Gridelli B, Piccolo G et al. A liver transplant candidate (fulminant hepatic failure from Amanita phalloides poisoning) as a multiorgan donor. Transplant Proc 1997: 29: 3343.
172. Tenderich C, Koerner MK, Posival H et al. Hemodynamic follow-up of cardiac allografts from poisoned donors. Transplantation 1998: 66: 1163.
173. O'Connor KJ, Delmonico FL. Organ donation and transplantation from poisoned donors. Transplant Rev 1999: 13: 52.
174. Naya MT, Miranda B, Cuende N, González I, Felipe C. Trasplantes renales con riñones procedentes de donantes fallecidos por intoxicación aguda por fármacos o tóxicos. Nefrología 1999: 19: 434.
175. Dribben WH, Kirk MA. Organ procurement and successful transplantation after malathion poisoning. Clin Toxicol 2001: 39: 633.
176. Caballero F, López-Navidad A, Cotorruelo J, Txoperena G. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation. Transplantation 2002: 74: 532.
177. Caballero F, López-Navidad A, Gómez M, Solá R. Successful transplantation of organs from a donor who died from acute cocaine intoxication. Clin Transplant 2003: 17: 89.
178. Freimark D, Czer LSC, Admon D et al. Donors with a history of cocaine use: effect on survival and rejection frequency after heart transplantation. J Heart Lung Transplant 1994: 13: 1138.
179. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000: 19: 1199.
180. Brems JJ, Merenda GO, Hayek ME, Kane RE, Flynn MF, Kaminski DL. Orthotopic liver transplantation resulting in amitriptyline toxicity in the recipient. Transplantation 1989: 48: 159.
181. Fattinger KE, Rentsch KM, Meier PJ, Dazzi H, Krähenbühl S. Safety of liver donation after fatal intoxication with the tricyclic antidepressant trimipramine. Transplantation 1996: 62: 1259.
182. Nghiem DD. Procurement of transplantable organs from brain dead transplant recipients. Transplant Proc 1997: 29: 3319.
183. Lowell JA, Taranto SE, Singer GG et al. Transplant recipients
184. Arvieux C, Cornforth B, Gunson B et al. Use of grafts procured from organ transplant recipients. Transplantation 1999: 67: 1074.
185. González-Segura C, Tormos P, Torras J et al. Recipients and donors: a life-paradox. Transplant Proc 1999: 31: 2496.
186. Frutos MA, Suarez MA, Santoyo J, Acedo C. Successful transplant of a liver from a kidney transplant recipient 11 years after transplantation. Transplantation 2000: 69: 1225.
187. Moreno EG, García GI, González-Pinto I, Gómez SR, Loinaz SC. Successful reuse of a liver graft. Br J Surg 1991: 78: 813.
188. Pasic M, Gallino A, Carrel T et al. Reuse of a transplanted heart. N Engl J Med 1993: 328: 319.
189. Andrés A, Lloveras J. Reuse of a transplanted kidney. N Engl J Med 1993: 328: 1644.
190. Moreno González E, Gómez R, Gonzalez Pinto I et al. Reuse of liver grafts after early death of the first recipient. World J Surg 1996: 20: 309.
191. Meiser BM, Überfuhr P, Reichenspurner H, Stang A, Kreuzer E, Reichart B. One heart Transplanted successfully twice. J Heart Lung Transplant 1994: 13: 339.
192. Antretter H, Plözl G, Margreiter J et al. Successful transfer of a cardiac allograft from a heterotopic to an orthotopic position 16 years after transplantation. Transplantation 2002: 74: 540.
193. Smith JA, Roberts M, McNeil K et al. Excellent outcome of cardiac transplantation using domino donor hearts. Eur J Cardiothorac Surg 1996: 10: 628.
194. Anyanwu AC, Rogers CA, Murday AJ. Variations in cardiac transplantation: comparisons between the United Kingdom and the United States. J Heart Lung Transplant 1999: 18: 297.
195. Monteiro E, Perdigoto R, Furtado AL. Liver transplantation for familial amyloid polyneuropathy. Hepatogastroenterology 1998: 45: 1375.
196. Hemming AW, Cattral MS, Chari RS et al. Domino liver transplantation for familial amyloid polyneuropathy. Liver Transpl Surg 1998: 4: 236.
197. Azoulay D, Samuel D, Castaing D et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999: 189: 584.
198. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000: 343: 404.
199. Spada M, Gridelli B, Colledan M et al. Extensive use of split liver for pediatric liver transplantation: a single-center experience. Liver Transplant 2000: 6: 415.
200. Deshpande RR, Bowles MJ, Vilca-Melendez H et al. Results of split liver transplantation in children. Ann Surg 2002: 236: 248.
201. Kilic M, Seu P, Stribling RJ, Ghalib R, Goss JA. In situ splitting of the cadaveric liver for two adult recipients. Transplantation 2001: 72: 1853.
202. Emond JC, Freeman RB, Renz JF, Yersiz H, Rogiers X, Busuttil RW. Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantation. Liver Transplant 2002: 8: 863.
203. Bresnahan BA, McBride MA, Cherikh WS, Hariharan S. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of United Network for Organ Sharing data. Transplantation 2001: 72: 256.
204. Merkel FK. Transplantation of small en bloc kidneys including a horseshoe kidney from donors aged 2 to 60 months to adult recipients: a 13-year experience. Transplant Proc 2001: 33: 3783.
205. Casavilla A, Ramirez C, Shapiro R et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995: 59: 197.
206. D'Alessandro AM, Hoffmann RM, Knechtle SJ et al. Successful extrarenal transplantation from non-heart-beating donors. Transplantation 1995: 59: 977.
207. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998: 338: 221.
208. González-Segura C, Castelao AM, Torras J et al. A good alternative to reduce the kidney shortage. Kidneys from nonheartbeating donors. Transplantation 1998: 65: 1465.
209. Alvarez J, Del Barrio R, Arias J et al. Non-heart-beating donors from the streets. An increasing donor pool source. Transplantation 2000: 70: 314.
210. D'Alessandro AM, Hoffmann RM, Knechtle SJ et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000: 128: 579.
211. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001: 357: 825.
212. Weber M, Dindo D, Demartines N, Ambühl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002: 347: 248.
213. López-Navidad A, Caballero F, Bartlett ST et al. Organs for transplantation. N Engl J Med 2000: 343: 1730.
214. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002: 346: 1074.
215. Bia MJ, Ramos EL, Danovitch GM et al. Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 1995: 60: 322.
216. Surman OS. Transplantation of the right hepatic lobe. N Engl J Med 2002: 347: 618.
217. Brown RS, Russo MW, Lai M et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003: 348: 818.
218. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM. Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation 2002: 74: 1349.
219. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995: 333: 333.
220. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002: 346: 580.
221. Andrews PA. Renal transplantation. BMJ 2002: 324: 530.
222. Mandal AK, Snyder JJ, Gilbertson DT, Collins AJ, Silkensen JR. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation 2003: 75: 494.
223. López-Navidad A Solá Puigjaner R., Spain's system for procuring organs operates in hospitals. BMJ 2002: 324: 1524.